Form D · Biotechnology

GenoPalate, Inc.

Milwaukee, WI · CIK 0001736000

Offering snapshot reported Mar 4, 2026 · SEC filing

Reported sold
$250K
Offering amount: $3M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 9, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 4, 2026Initial$250,000No comparison1SEC filing
Dec 10, 2024Initial$3,000,000No comparison4SEC filing
Oct 21, 2022Initial$6,047,456No comparison6SEC filing
Dec 29, 2020Initial$3,999,955No comparison9SEC filing
Dec 16, 2019Initial$1,000,000No comparison1SEC filing
Dec 3, 2018Initial$709,095No comparison8SEC filing
May 3, 2018Amendment$357,065$49,999vs Mar 30, 20186SEC filing
Mar 30, 2018Initial$307,066No comparison6SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-575431

Source: Form D, filed Mar 4, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
John T. Byrnes Director
Brian Gagne Executive
Dennis Hodges Executive
Michael Mc Nally Executive
Asif Naseem Director, Executive
Chad Raube Director
Bradley Simmons Director
Joseph M. Smith Director
Harald Steltzer Director
Yi Zhang Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
10437 W Innovation Dr Ste 465
Milwaukee, WI, 53226